Atıf Formatları
EVALUATION OF ACCESS TO MONOCLONAL ANTIBODY DRUGS IN TURKIYE BETWEEN 2017-2022
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

E. H. Vural, "EVALUATION OF ACCESS TO MONOCLONAL ANTIBODY DRUGS IN TURKIYE BETWEEN 2017-2022," 2 nd INTERNATIONAL AND 27th NATIONAL PHARMACOLOGY CONGRESS , Antalya, Turkey, pp.273-274, 2023

Vural, E. H. 2023. EVALUATION OF ACCESS TO MONOCLONAL ANTIBODY DRUGS IN TURKIYE BETWEEN 2017-2022. 2 nd INTERNATIONAL AND 27th NATIONAL PHARMACOLOGY CONGRESS , (Antalya, Turkey), 273-274.

Vural, E. H., (2023). EVALUATION OF ACCESS TO MONOCLONAL ANTIBODY DRUGS IN TURKIYE BETWEEN 2017-2022 . 2 nd INTERNATIONAL AND 27th NATIONAL PHARMACOLOGY CONGRESS (pp.273-274). Antalya, Turkey

Vural, ELİF. "EVALUATION OF ACCESS TO MONOCLONAL ANTIBODY DRUGS IN TURKIYE BETWEEN 2017-2022," 2 nd INTERNATIONAL AND 27th NATIONAL PHARMACOLOGY CONGRESS, Antalya, Turkey, 2023

Vural, ELİF H. . "EVALUATION OF ACCESS TO MONOCLONAL ANTIBODY DRUGS IN TURKIYE BETWEEN 2017-2022." 2 nd INTERNATIONAL AND 27th NATIONAL PHARMACOLOGY CONGRESS , Antalya, Turkey, pp.273-274, 2023

Vural, E. H. (2023) . "EVALUATION OF ACCESS TO MONOCLONAL ANTIBODY DRUGS IN TURKIYE BETWEEN 2017-2022." 2 nd INTERNATIONAL AND 27th NATIONAL PHARMACOLOGY CONGRESS , Antalya, Turkey, pp.273-274.

@conferencepaper{conferencepaper, author={ELİF HİLAL VURAL}, title={EVALUATION OF ACCESS TO MONOCLONAL ANTIBODY DRUGS IN TURKIYE BETWEEN 2017-2022}, congress name={2 nd INTERNATIONAL AND 27th NATIONAL PHARMACOLOGY CONGRESS}, city={Antalya}, country={Turkey}, year={2023}, pages={273-274} }